本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Portage Biotech Inc.

7.40
-0.5899-7.38%
成交量:3.12万
成交额:23.36万
市值:1,217.65万
市盈率:-0.12
高:7.75
开:7.22
低:7.22
收:7.99
数据加载中...
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/15

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/10/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/23

关联方拟减持公告

Form 144 | Portage Biotech 董事 Steven Mintz 拟减持7577股,总价约12.1万美元
2024/09/20

关联方拟减持公告

Form 144 | Portage Biotech董事 Gregory Bailey拟减持7万股,总价约123万美元
2024/08/14

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/01

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/11/04

SEC问询函

Form CORRESP - Correspondence
2023/11/01

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/07/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/08/01

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/03/04

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/07/29

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/26

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/05

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/05

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/17

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2019/12/30

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]